You are currently viewing a new version of our website. To view the old version click .
Cancers | Editor’s Choice Articles Published in 2024 and Special Issues in the “Cancer Immunology and Immunotherapy” Section

Cancers | Editor’s Choice Articles Published in 2024 and Special Issues in the “Cancer Immunology and Immunotherapy” Section

15 May 2025


We are delighted to share some of the most viewed papers in the “Cancer Immunology and Immunotherapy” Section, that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, a few Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that may be of interest to you. 

“The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis”
by Obada Ababneh, Alina Ghazou, Mohmmad Alawajneh, Saleh Alhaj Mohammad, Abdullah Bani-Hani, Nasr Alrabadi and Aditya Shreenivas
Cancers 2024, 16(5), 900; https://doi.org/10.3390/cancers16050900
Available online: https://www.mdpi.com/2072-6694/16/5/900 

“Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study”
by Mariana Bastos-Oreiro, Antonio Gutierrez, Almudena Cabero, Javier López, Paola Villafuerte, Ana Jiménez-Ubieto, Raquel de Oña, Adolfo De la Fuente, Belén Navarro, Javier Peñalver et al.
Cancers 2024, 16(7), 1285; https://doi.org/10.3390/cancers16071285
Available online: https://www.mdpi.com/2072-6694/16/7/1285 

“Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy”
by Olamide T. Olaoba, Temitope I. Adelusi, Ming Yang, Tessa Maidens, Eric T. Kimchi, Kevin F. Staveley-O’Carroll and Guangfu Li
Cancers 2024, 16(10), 1808; https://doi.org/10.3390/cancers16101808
Available online: https://www.mdpi.com/2072-6694/16/10/1808 

“Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer”
by Javier David Benitez Fuentes, Jorge Bartolome Arcilla, Kauzar Mohamed Mohamed, Alfonso Lopez de Sa, Alicia de Luna Aguilar, Kissy Guevara-Hoyer, Pablo Ballestin Martinez, Antonio David Lazaro Sanchez, Edgardo D. Carosella, Alberto Ocaña et al.
Cancers 2024, 16(24), 4266; https://doi.org/10.3390/cancers16244266
Available online: https://www.mdpi.com/2072-6694/16/24/4266 

“The Transformative Role of 3D Culture Models in Triple-Negative Breast Cancer Research”
by Xavier S. Bittman-Soto, Evelyn S. Thomas, Madeline E. Ganshert, Laura L. Mendez-Santacruz and J. Chuck Harrell
Cancers 2024, 16(10), 1859; https://doi.org/10.3390/cancers16101859
Available online: https://www.mdpi.com/2072-6694/16/10/1859

Special Issues:

 

 Immunotherapy in Melanoma: Recent Advances and Future Directions (2nd Edition)
Guest Editors: Dr. Dimitrios C. Ziogas and Prof. Dr. Helen Gogas
Submission deadline: 31 August 2025

Immunomodulation in Cancer Treatment
Guest Editor: Dr. Samuel D. Saibil
Submission deadline: 31 August 2025

 

CAR T-Cell Therapy and Multiple Myeloma
Guest Editor: Dr. Jo Caers
Submission deadline: 31 August 2025

Immunotherapy of Glioblastoma
Guest Editor: Dr. Mao Li
Submission deadline: 16 August 2025

You are invited to view and submit relevant papers to Cancers using the following link: https://www.mdpi.com/journal/cancers

Cancers Editorial Office